Hutch News

Hutch News

Stories tagged 'vaccine'

6 questions in cancer immunotherapy

From cancer vaccines to engineered T cells, experts weigh in on the big unknowns

March 18, 2016 | by Susan Keown / Fred Hutch News Service

Fred Hutch immunotherapy experts share their perspectives on a few of the big questions in cancer immunotherapy research — and the steps that they and their colleagues are taking to answer them as quickly as they can.

View story >


Building a better protein in the hope of better therapies

Researchers design and create donut-shaped proteins from scratch

Dec. 16, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

Researchers design and create donut-shaped proteins from scratch that could one day help yield more potent vaccines, more powerful growth factors to stimulate the growth of cancer-fighting immune cells in stem cell or cord blood transplants, or even a molecular sponge to soak up toxins in the body after poisoning.

View story >


HPV vaccines work, so why do so few states require them?

Only Virginia, Washington, D.C., and soon, Rhode Island, include the cancer-preventing vaccine as a school requirement

July 14, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

Nine years after the HPV vaccine was first approved in the U.S., only Virginia and Washington, D.C., currently require the vaccine for school entry, according to new research.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.